Stanford professor Russ Altman emphasizes that AI is opening new opportunities to understand how medicines interact with specific proteins, and build more highly customized therapies. He points to DeepMind’s AlphaFold 2 deep learning system as a particularly powerful new tool for re-envisioning how drugs are discovered and designed.
Related

Dave Vasen,
brightwheel
Problem-Solving for a Unique Market [Entire Talk]
Listening to potential customers’ needs can be the key to unlocking a successful startup idea
Video
46 minutes
Dave Vasen,
brightwheel
Problem-Solving for a Unique Market [Entire Talk]
Listening to potential customers’ needs can be the key to unlocking a successful startup idea

Maya Arengo,
Stanford University
Scaling a Climate Tech Company
An eCorner mini guide on the unique challenges that climate tech companies face when scaling, and how to overcome them.
Article
5 minutes

Maya Arengo,
Stanford University
So You Want to Be a Climate Tech Entrepreneur
An eCorner mini guide on the current range of technologies within climate tech, and what kinds of funding for founders to secure.
Article
5 minutes